Here's What Key Metrics Tell Us About Sweetgreen (SG) Q2 Earnings

Sweetgreen (SG) reported Q2 2025 revenue of $185.58 million, a modest 0.5% year-over-year increase, but missed the Zacks Consensus Estimate by 3.11%. The company posted an EPS of -$0.20, significantly wider than the -$0.12 consensus. Critically, same-store sales declined 7.6%, underperforming the -5.3% analyst estimate and signaling underlying operational weakness despite exceeding targets for new restaurant openings. This financial underperformance contributed to the stock's recent 7.7% decline and a Zacks Rank #4 (Sell) rating, indicating potential near-term underperformance.

Analysis

Sweetgreen's (SG) second-quarter 2025 results reveal significant operational challenges despite a marginal 0.5% year-over-year revenue increase to $185.58 million. This top-line figure missed the Zacks Consensus Estimate by 3.11%, indicating a failure to meet market expectations. The profitability picture is more concerning, with Earnings Per Share (EPS) deteriorating to -$0.20 from -$0.13 in the prior-year quarter and representing a substantial -66.67% surprise compared to the -$0.12 consensus estimate. The core weakness is evident in the key metrics, where a same-store sales decline of -7.6% significantly underperformed the analyst estimate of -5.3%, signaling a sharp contraction in demand at existing locations. While the company exceeded its new restaurant opening targets (9 vs. 5 estimated) and total store count (260 vs. 256 estimated), this expansion is failing to offset the fundamental weakness in its core business. This underperformance has been reflected in the stock's -7.7% return over the past month, lagging the S&P 500 composite's +1.9% gain, and is underscored by a Zacks Rank #4 (Sell) rating, suggesting continued near-term pressure.

Key Decisions for Investors

• Investors should exercise caution, as the -7.6% decline in same-store sales, which is worse than already negative estimates, points to deteriorating unit economics that new store openings are failing to mask.
• The significant miss on EPS, with losses widening year-over-year, warrants close scrutiny of the company's path to profitability and cost control measures.
• Given the poor fundamental performance, recent stock underperformance of -7.7%, and a formal 'Sell' rating from Zacks, it may be prudent to avoid initiating or adding to positions until there is evidence of a turnaround in same-store sales trends.